Biotyx Medical (shenzhen) Co., Ltd.
Clinical trials sponsored by Biotyx Medical (shenzhen) Co., Ltd., explained in plain language.
-
Iron scaffold melts away after opening clogged arteries in heart disease trial
Disease control OngoingThis study tests a new device called the Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (IBS) in 1059 people with coronary artery disease. The scaffold props open blocked heart arteries and slowly dissolves over time, releasing a drug to prevent re-blockage. The go…
Phase: NA • Sponsor: Biotyx Medical (Shenzhen) Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 11:58 UTC
-
Dissolving stent trial aims to clear clogged heart arteries
Disease control OngoingThis study is testing a new type of heart stent that is made of iron and designed to dissolve in the body over time. It is being compared to a standard, permanent metal stent in 518 patients with coronary artery disease. The main goal is to see if the dissolving stent is as safe …
Phase: NA • Sponsor: Biotyx Medical (Shenzhen) Co., Ltd. • Aim: Disease control
Last updated Apr 20, 2026 16:14 UTC